AbCellera Biologics CFO Booth Andrew Buys 42,600 Shares at $3.42/Shr

AbCellera Biologics Inc. (ABCL) has announced that Chief Financial Officer Booth Andrew has acquired 42,600 shares at a price of $3.42 per share on February 27, 2026. Additionally, 10% Owner Thermopylae Holdings Ltd. has purchased 177,457 shares at a price of $3.27 per share on February 26, 2026.